Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6516
    -0.0002 (-0.04%)
     
  • OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD

    2,254.80
    +16.40 (+0.73%)
     
  • Bitcoin AUD

    107,296.23
    -1,109.72 (-1.02%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6040
    +0.0006 (+0.10%)
     
  • AUD/NZD

    1.0902
    -0.0001 (-0.01%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     

Top Ranked Momentum Stocks to Buy for February 4th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 4th:

RLI Corp. (RLI): This is an insurance holding company, underwrites property and casualty insurance has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.

RLI Corp. Price and Consensus

RLI Corp. Price and Consensus
RLI Corp. Price and Consensus

RLI Corp. price-consensus-chart | RLI Corp. Quote

RLI’s shares gained 3.1% over the last one month over the S&P 500’s growth of 0.1%. The company possesses a Momentum Score of A.

RLI Corp. Price

RLI Corp. Price
RLI Corp. Price

RLI Corp. price | RLI Corp. Quote

ADVERTISEMENT

Mellanox Technologies, Ltd. (MLNX): This is a fabless semiconductor company, designs, manufactures, markets, and sells interconnect products and solutions has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.8% over the last 60 days.

Mellanox Technologies, Ltd. Price and Consensus

Mellanox Technologies, Ltd. Price and Consensus
Mellanox Technologies, Ltd. Price and Consensus

Mellanox Technologies, Ltd. price-consensus-chart | Mellanox Technologies, Ltd. Quote

Mellanox Technologies’ shares gained 1.8% over the last one month. The company possesses a Momentum Score of A.

Mellanox Technologies, Ltd. Price

Mellanox Technologies, Ltd. Price
Mellanox Technologies, Ltd. Price

Mellanox Technologies, Ltd. price | Mellanox Technologies, Ltd. Quote

Xenon Pharmaceuticals Inc. (XENE): This ís a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 29.7% over the last 60 days.

Xenon Pharmaceuticals Inc. Price and Consensus

Xenon Pharmaceuticals Inc. Price and Consensus
Xenon Pharmaceuticals Inc. Price and Consensus

Xenon Pharmaceuticals Inc. price-consensus-chart | Xenon Pharmaceuticals Inc. Quote

Xenon Pharmaceuticals shares gained 4.8% over the last one month. The company possesses a Momentum Score of B.

Xenon Pharmaceuticals Inc. Price

Xenon Pharmaceuticals Inc. Price
Xenon Pharmaceuticals Inc. Price

Xenon Pharmaceuticals Inc. price | Xenon Pharmaceuticals Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.7% per year. So be sure to give these hand-picked 7 your immediate attention.

See 7 handpicked stocks now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Xenon Pharmaceuticals Inc. (XENE) : Free Stock Analysis Report
 
RLI Corp. (RLI) : Free Stock Analysis Report
 
Mellanox Technologies, Ltd. (MLNX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research